Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension”

861 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 861 results

Not applicableStudy completedNCT01789996
What this trial is testing

The Six Minute Walk Test: Influence of Instruction on Results

Who this might be right for
Interstitial Lung Disease
Inova Health Care Services 45
Not applicableLooking for participantsNCT02249923
What this trial is testing

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

Who this might be right for
Pulmonary Vascular DiseasePulmonary Arterial Hypertension
New York Medical College 2,500
Post-approval studies (Phase 4)Study completedNCT00373360
What this trial is testing

Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin

Who this might be right for
Pulmonary Hypertension
United Therapeutics 10
Large-scale testing (Phase 3)Study completedNCT00644605
What this trial is testing

Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 275
Not applicableStudy completedNCT01659411
What this trial is testing

Adult Congenital Heart Disease Registry (QuERI)

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 217
Not applicableStudy completedNCT01572077
What this trial is testing

Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Ottawa Heart Institute Research Corporation 20
Not applicableStudy completedNCT03278002
What this trial is testing

A Registry for Patients Taking Uptravi

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 800
Large-scale testing (Phase 3)Study completedNCT00549302
What this trial is testing

Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

Who this might be right for
Hypertension, Pulmonary
Eli Lilly and Company 357
Post-approval studies (Phase 4)Ended earlyNCT02968901
What this trial is testing

Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 46
Large-scale testing (Phase 3)Study completedNCT00080457
What this trial is testing

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Encysive Pharmaceuticals 240
Testing effectiveness (Phase 2)Ended earlyNCT01179737
What this trial is testing

Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 23
Testing effectiveness (Phase 2)Study completedNCT02790450
What this trial is testing

Acute Effects of Benzbromaron on the Pulmonary Circulation

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension
Medical University of Graz 10
Large-scale testing (Phase 3)Ended earlyNCT00811018
What this trial is testing

A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer 1,192
Large-scale testing (Phase 3)Ended earlyNCT04084678
What this trial is testing

Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects

Who this might be right for
Pulmonary HypertensionPulmonary Arterial Hypertension
United Therapeutics 10
Testing effectiveness (Phase 2)Study completedNCT04483115
What this trial is testing

Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Vigonvita Life Sciences 60
Not applicableStudy completedNCT03195959
What this trial is testing

Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension

Who this might be right for
Pulmonary Hypertension
University of Zurich 44
Not applicableEnded earlyNCT02899533
What this trial is testing

[18F]FES PET/CT in PAH

Who this might be right for
Pulmonary Arterial Hypertension
University of Pennsylvania 5
Post-approval studies (Phase 4)Study completedNCT03497689
What this trial is testing

EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 36
Not applicableNot Yet RecruitingNCT07801950
What this trial is testing

Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Healthy Individuals H

Who this might be right for
HealthyHealthy AdultHigh Altitude Effects+4 more
Silvia Ulrich Somaini 14
Post-approval studies (Phase 4)Active Not RecruitingNCT05825417
What this trial is testing

Pulmonary Hypertension: Intensification and Personalisation of Combination Rx

Who this might be right for
Pulmonary Arterial Hypertension
Sheffield Teaching Hospitals NHS Foundation Trust 70
Next Page